Gallbladder Cancer.

Marcinak, Clayton T; Abbott, Daniel E

Gallbladder Cancer.

Marcinak, Clayton T; Abbott, Daniel E.

Afiliación

Marcinak CT; Division of Surgical Oncology, Department of Surgery, University of Wisconsin-Madison, 7375 Clinical Science Center, 600 Highland Avenue, Madison, WI, 53792, USA.
Abbott DE; Division of Surgical Oncology, Department of Surgery, University of Wisconsin-Madison, 7375 Clinical Science Center, 600 Highland Avenue, Madison, WI, 53792, USA. abbott@surgery.wisc.edu.

Cancer Treat Res ; 192: 147-163, 2024.

Article en En | MEDLINE | ID: mdl-39212920

ABSTRACT

ABSTRACT

Gallbladder carcinoma (GBC) is the most common biliary epithelial malignancy, with an estimated incidence of 1.13 cases per 100,000 in the United States (Hundal and Shaffer in Clin Epidemiol 699-109, 2014 1; Henley et al. in Cancer Epidemiol Biomarkers Prev 241319-1326, 2015 2). The insidious nature and late presentation of this disease place it among the most lethal invasive neoplasms. Gallbladder cancer spreads early by lymphatic or hematogenous metastasis, as well as by direct invasion into the liver. While surgery may be curative at early stages, both surgical and nonsurgical treatments remain largely unsuccessful in patients with more advanced diseases (Rahman et al. in Cancer Med 6874-880, 2017 3).

Asunto(s)

Neoplasias de la Vesícula Biliar; Humanos; Neoplasias de la Vesícula Biliar/terapia; Neoplasias de la Vesícula Biliar/epidemiología; Neoplasias de la Vesícula Biliar/patología; Neoplasias de la Vesícula Biliar/diagnóstico

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Vesícula Biliar Límite: Humans Idioma: En Revista: Cancer Treat Res Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google